<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms<sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study-Reference-Cited by-同舟云学术

¹⁸F-AlF-NOTA-Octreotide Outperforms⁶⁸Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study

Published:2022-10-20 Issue:4 Volume:64 Page:632-638
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Pauwels Elin,Cleeren Frederik,Tshibangu Térence,Koole Michel,Serdons Kim,Boeckxstaens Lennert,Dekervel Jeroen,Vandamme Timon,Lybaert Willem,den Broeck Bliede Van,Laenen Annouschka,Clement Paul M.,Geboes Karen,Cutsem Eric Van,Stroobants Sigrid,Verslype Chris,Bormans Guy,Deroose Christophe M.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference13 articles.

1. Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA;Bozkurt;Eur J Nucl Med Mol Imaging.,2017

2. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

3. Somatostatin receptor PET ligands: the next generation for clinical practice;Pauwels;Am J Nucl Med Mol Imaging.,2018

4. Clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms;Long;Clin Nucl Med.,2019

5. [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients;Pauwels;Eur J Nucl Med Mol Imaging.,2020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

3. A Rare Case of Follicular Dendritic Cell Tumor of the Abdominal Cavity Visualized by 18F-AlF-NOTA-Octreotide PET/CT;Clinical Nuclear Medicine;2024-07-03

4. Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-15

5. Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms;Expert Review of Endocrinology & Metabolism;2024-06-05